AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11912355 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost vs Brimonidine
Number of subjects: 379
Study 11912355 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 379
Study 9767193 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antiplatelet therapy
Number of subjects: 0
Study 9767193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of aspirin and dipyridamole
Number of subjects: 0
Study 9767193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antiplatelet agents (e.g. aspirin and clopidogrel)
Number of subjects: 0
Study 9767193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antiplatelet agents and oral anticoagulants
Number of subjects: 0
Study 9767193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antithrombotic and cholesterol-lowering medications (statins)
Number of subjects: 0
Study 1995788 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered deuterated pyridoxine (PN)
Number of subjects: 5
Study 1995788 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered deuterated pyridoxine-5'-beta-D-glucoside (PN-glucoside)
Number of subjects: 5
Study 1995788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenously administered pyridoxine-5'-beta-D-glucoside (PN-glucoside)
Number of subjects: 5
Study 6516515 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionic low osmolar ioxaglat (Hexabrix)
Number of subjects: 80
Study 6516515 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ionic low osmolar iopamidol (Solutrast 370)
Number of subjects: 80
Study 6516515 — intervention group
Group type: COMPARATOR
Intervention: Conventional ionic and high-osmolar ioxitalamat (Telebrix 350)
Number of subjects: 80
Study 30700347 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorquinaldol‐promestriene vaginal tablets
Number of subjects: 98
Study 30700347 — intervention group
Group type: COMPARATOR
Intervention: Opin suppositories
Number of subjects: 98
Study 29791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper removable appliance with digital springs (Group 1)
Number of subjects: 30
Study 29791690 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-reinforced glass ionomer cement bite pads on the lower first molars (Group 2)
Number of subjects: 30
Study 26523433 — intervention group
Group type: EXPERIMENTAL
Intervention: PUC‐ETT
Number of subjects: 102
Study 26523433 — intervention group
Group type: EXPERIMENTAL
Intervention: PUC‐CASS‐ETT
Number of subjects: 102
Study 26523433 — intervention group
Group type: COMPARATOR
Intervention: PVC‐ETT
Number of subjects: 102
Study 24625322 — intervention group
Group type: EXPERIMENTAL
Intervention: PegIFNα (type Y peginterferon α‐2b 90 μg, 135 μg, 180 μg and PegIFNα‐2a 180 μg, respectively, once a week) and ribavirin (< 75 kg, 1000 mg daily and ≥ 75 kg, 1200 mg daily) for 48 weeks
Number of subjects: 32
Study 22388710 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids plus pentoxifylline (prednisolone 40 mg/day plus pentoxifylline 400 mg thrice/day)
Number of subjects: 70
Study 22388710 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids alone (prednisolone 40 mg/day)
Number of subjects: 70
Study 22388710 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids plus pentoxifylline
Number of subjects: 70
Study 22388710 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids alone
Number of subjects: 70
Study 20820127 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional care program
Number of subjects: 128
Study 20820127 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study 18553045 — intervention group
Group type: EXPERIMENTAL
Intervention: New appendicitis inflammatory response score
Number of subjects: 545
Study 18553045 — intervention group
Group type: COMPARATOR
Intervention: Alvarado score
Number of subjects: 545
Study 16822121 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-cuing with varied cue-stimulus intervals
Number of subjects: 0
Study 16822121 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-cuing with low probability of task change
Number of subjects: 0
Study 16822121 — intervention group
Group type: COMPARATOR
Intervention: Control condition based on previous studies by Logan and Bundesen
Number of subjects: 0
Study 12814685 — intervention group
Group type: EXPERIMENTAL
Intervention: 250mg Levofloxacin p.o. given approximately 60 minutes prior to ureteroscopy
Number of subjects: 113
Study 12814685 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 113
Study 11060935 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure with counterconditioning (CC)
Number of subjects: 34
Study 11060935 — intervention group
Group type: COMPARATOR
Intervention: Regular one-session exposure (EXP)
Number of subjects: 34
Study 9220094 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Visual Field (LVF)
Number of subjects: 12
Study 9220094 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Visual Field (RVF)
Number of subjects: 12
Study 9220094 — intervention group
Group type: EXPERIMENTAL
Intervention: RVF
Number of subjects: 12
Study 9220094 — intervention group
Group type: EXPERIMENTAL
Intervention: LVF
Number of subjects: 12
Study 8477163 — intervention group
Group type: EXPERIMENTAL
Intervention: High umbilical arterial catheter position
Number of subjects: 308
Study 8477163 — intervention group
Group type: COMPARATOR
Intervention: Low umbilical arterial catheter position
Number of subjects: 308
Study 3718170 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment (double-blind placebo-controlled)
Number of subjects: 27
Study 3718170 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal from neuroleptic treatment
Number of subjects: 27
Study 3718170 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic treatment
Number of subjects: 27
Study 31606226 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily chewing gum (Arm A)
Number of subjects: 91
Study 31606226 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Arm B)
Number of subjects: 91
Study 31606226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (Arm A and Arm B)
Number of subjects: 91
Study 29782907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (ITB) bolus
Number of subjects: 13
Study 29782907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 27773665 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 1026
Study 27773665 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 1026
Study 23946318 — intervention group
Group type: EXPERIMENTAL
Intervention: eletriptan 40 mg (ELE-40)
Number of subjects: 971
Study 23946318 — intervention group
Group type: EXPERIMENTAL
Intervention: eletriptan 80 mg (ELE-80)
Number of subjects: 971
Study 23946318 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 971
Study 21903737 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium 400 μg bid
Number of subjects: 30
Study 21903737 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 8 μg once daily
Number of subjects: 30
Study 21903737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 20350669 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic care combined with exercise
Number of subjects: 20
Study 20350669 — intervention group
Group type: COMPARATOR
Intervention: Exercise only
Number of subjects: 20
Study 18367240 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg PO daily for 1 week)
Number of subjects: 20
Study 18367240 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen challenge
Number of subjects: 20
Study 18367240 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution challenge
Number of subjects: 20
Study 18367240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15897990 — intervention group
Group type: COMPARATOR
Intervention: nelfinavir
Number of subjects: 653
Study 15897990 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir
Number of subjects: 653
Study 12457377 — intervention group
Group type: EXPERIMENTAL
Intervention: d-chlorpheniramine (6 mg)
Number of subjects: 0
Study 12457377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10357448 — intervention group
Group type: COMPARATOR
Intervention: Artificial grammar learning
Number of subjects: 13
Study 10357448 — intervention group
Group type: COMPARATOR
Intervention: Artificial grammar learning with transfer to novel lettersets
Number of subjects: 13
Study 10357448 — intervention group
Group type: COMPARATOR
Intervention: Prototype learning
Number of subjects: 13
Study 9121619 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (not specified)
Number of subjects: 16
Study 1988514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime, 2 g intravenously every 8 h (n = 16)
Number of subjects: 33
Study 1988514 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone, 2 g intravenously every 24 h (n = 17)
Number of subjects: 33
Study 1988514 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone or Cefotaxime
Number of subjects: 33
Study 1988514 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 33
Study 6349160 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-assisted step test (S)
Number of subjects: 4
Study 6349160 — intervention group
Group type: COMPARATOR
Intervention: Bicycle ergometer (B)
Number of subjects: 4
Study 31489420 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive technique (third generation chemical decaying technique plus traditional decaying method)
Number of subjects: 60
Study 31489420 — intervention group
Group type: COMPARATOR
Intervention: Traditional decaying method
Number of subjects: 60
Study 30856079 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU daily for 2 months)
Number of subjects: 40
Study 27707834 — intervention group
Group type: EXPERIMENTAL
Intervention: IPC/JIT device within lower limb cast
Number of subjects: 142
Study 23827527 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted influenza immunisation programme in intervention UMCs
Number of subjects: 3367
Study 23827527 — intervention group
Group type: COMPARATOR
Intervention: Control UMCs
Number of subjects: 3367
Study 22847969 — intervention group
Group type: EXPERIMENTAL
Intervention: DECISION+2 training program (2-hour online tutorial + 2-hour interactive seminar)
Number of subjects: 359
Study 22847969 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 359
Study 22847969 — intervention group
Group type: EXPERIMENTAL
Intervention: DECISION+2 training program
Number of subjects: 359
Study 22847969 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 359
Study 19773329 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthritis self management programme plus education booklet
Number of subjects: 812
Study 19773329 — intervention group
Group type: COMPARATOR
Intervention: Education booklet alone (standard care control group)
Number of subjects: 812
Study 17355251 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (group 2)
Number of subjects: 61
Study 17355251 — intervention group
Group type: COMPARATOR
Intervention: Scleral buckling (group 1)
Number of subjects: 61
Study 15197504 — intervention group
Group type: EXPERIMENTAL
Intervention: (11)C-metomidate (MTO)
Number of subjects: 16
Study 15197504 — intervention group
Group type: COMPARATOR
Intervention: (18)F-fluorodeoxyglucose (FDG)
Number of subjects: 16
Study 11144998 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilidine (1.5 mg/kg) administered on the day of dialysis
Number of subjects: 9
Study 11144998 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilidine (1.5 mg/kg) administered on a day in the dialysis-free interval
Number of subjects: 9
Study 11144998 — intervention group
Group type: COMPARATOR
Intervention: Comparison with healthy volunteers
Number of subjects: 9
Study 9694404 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral melatonin administered at 12.30 hr
Number of subjects: 16
Study 9694404 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study 7861681 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger-drawing for encoding
Number of subjects: 40
Study 7861681 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger-drawing for searching
Number of subjects: 40
Study 7861681 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger-drawing for both encoding and searching
Number of subjects: 40
Study 7861681 — intervention group
Group type: COMPARATOR
Intervention: Imagery encoding
Number of subjects: 40
Study 7861681 — intervention group
Group type: COMPARATOR
Intervention: Verbal encoding
Number of subjects: 40
Study 2768537 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual tooth-brushing
Number of subjects: 108
Study 2768537 — intervention group
Group type: EXPERIMENTAL
Intervention: Power toothbrushing
Number of subjects: 108
Study 2768537 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrushing plus irrigation
Number of subjects: 108
Study 2768537 — intervention group
Group type: EXPERIMENTAL
Intervention: Power toothbrushing plus irrigation
Number of subjects: 108
Study 29210957 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine gum (CAF) 400 mg; 4.1 ± 0.5 mg·kg
Number of subjects: 14
Study 29210957 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum (PLC)
Number of subjects: 14
Study 29210957 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine gum (CAF)
Number of subjects: 14
Study 29210957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance (reaction time and Stroop test)
Number of subjects: 14
Study 31730630 — intervention group
Group type: EXPERIMENTAL
Intervention: MCH-ART intervention (integrated maternal/pediatric care)
Number of subjects: 0
Study 31730630 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study 31730630 — intervention group
Group type: EXPERIMENTAL
Intervention: MCH-ART intervention
Number of subjects: 0
Study 29069628 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 92
Study 26124486 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed/Cisplatin
Number of subjects: 321
Study 26124486 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine/Cisplatin
Number of subjects: 321
Study 23693129 — intervention group
Group type: EXPERIMENTAL
Intervention: Body acupuncture; Sa-am acupuncture
Number of subjects: 150
Study 23693129 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 21045662 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL) by riboflavin/UV light
Number of subjects: 10
Study 19114204 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg/d)
Number of subjects: 200
Study 19114204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 17006067 — intervention group
Group type: EXPERIMENTAL
Intervention: Combitube (ETC)
Number of subjects: 120
Study 17006067 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 120
Study 12732501 — intervention group
Group type: EXPERIMENTAL
Intervention: Unrelated donor stem cell transplantation (UD‐SCT)
Number of subjects: 81
Study 12732501 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 81
Study 10971307 — intervention group
Group type: EXPERIMENTAL
Intervention: Asimadoline 5 mg
Number of subjects: 24
Study 10971307 — intervention group
Group type: EXPERIMENTAL
Intervention: Asimadoline 10 mg
Number of subjects: 24
Study 10971307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8855175 — intervention group
Group type: EXPERIMENTAL
Intervention: T-alpha1 900 microg/m2 body surface area twice weekly for 6 months
Number of subjects: 33
Study 8855175 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa (IFN-alpha) 5 MU three times weekly for 6 months
Number of subjects: 33
Study 8855175 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa (IFN-alpha)
Number of subjects: 33
Study 1629477 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous presentation of stimuli (profile analysis)
Number of subjects: 0
Study 1629477 — intervention group
Group type: COMPARATOR
Intervention: Successive presentation of stimuli
Number of subjects: 0
Study 1629477 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous presentation of tonal complexes (10 to 11 components)
Number of subjects: 0
Study 1629477 — intervention group
Group type: COMPARATOR
Intervention: Successive presentation of tonal complexes (10 to 11 components)
Number of subjects: 0
Study 6812685 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 40 mg every 48 hours
Number of subjects: 0
Study 6812685 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 40 mg every 72 hours
Number of subjects: 0
Study 6812685 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens of aspirin
Number of subjects: 0
Study 31116392 — intervention group
Group type: EXPERIMENTAL
Intervention: Online professional development program for preschool teachers
Number of subjects: 818
Study 31116392 — intervention group
Group type: COMPARATOR
Intervention: In-person delivery of professional development to preschool teachers (Phase I)
Number of subjects: 818
Study 31116392 — intervention group
Group type: EXPERIMENTAL
Intervention: Online delivery of professional development to preschool teachers (Phase II)
Number of subjects: 818
Study 31116392 — intervention group
Group type: EXPERIMENTAL
Intervention: Statewide dissemination of SHAPES (Phase III)
Number of subjects: 818
Study 28237867 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 392
Study 28237867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 26233808 — intervention group
Group type: EXPERIMENTAL
Intervention: NABOTA
Number of subjects: 197
Study 26233808 — intervention group
Group type: COMPARATOR
Intervention: Botox
Number of subjects: 197
Study 23707410 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-degree bent tip (Group 1)
Number of subjects: 90
Study 23707410 — intervention group
Group type: COMPARATOR
Intervention: 12-degree bent tip (Group 2)
Number of subjects: 90
Study 21550310 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate (500 mg/day for 1 week, then once a week to complete 12 weeks)
Number of subjects: 1516
Study 21550310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1516
Study 21550310 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate
Number of subjects: 1516
Study 19506780 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment (MBT)
Number of subjects: 0
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological stress challenge (Trier Social Stress Test - TSST)
Number of subjects: 24
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy normal weight subjects
Number of subjects: 24
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with BED
Number of subjects: 24
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol responders
Number of subjects: 24
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in ghrelin
Number of subjects: 24
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher quartile of ghrelin response
Number of subjects: 24
Study 17560728 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating related scores
Number of subjects: 24
Study 15224627 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart sounds feedback via headphones
Number of subjects: 64
Study 15224627 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart sounds feedback via loudspeakers audible to observers
Number of subjects: 64
Study 15224627 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study 12562140 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance P receptor antagonists (SPAs) aprepitant (MK‐0869) and compound A
Number of subjects: 0
Study 12562140 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study 10194615 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised Controlled Trials (RCTs)
Number of subjects: 0
Study 10194615 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed Consent
Number of subjects: 0
Study 10194615 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs
Number of subjects: 0
Study 7661204 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsler grid testing
Number of subjects: 15
Study 7661204 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangent screen
Number of subjects: 15
Study 2568350 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordesmethyldiazepam (long-acting benzodiazepine)
Number of subjects: 0
Study 2568350 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (short-acting benzodiazepine)
Number of subjects: 0
Study 68228 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent constant‐dosage heparin
Number of subjects: 76
Study 68228 — intervention group
Group type: COMPARATOR
Intervention: continuously infused heparin with laboratory control
Number of subjects: 76
Study 68228 — intervention group
Group type: COMPARATOR
Intervention: surgical wounds
Number of subjects: 76
Study 68228 — intervention group
Group type: COMPARATOR
Intervention: arterial and venous puncture sites
Number of subjects: 76
Study 30496510 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Ultrasound (PUS) treatment
Number of subjects: 47
Study 30496510 — intervention group
Group type: COMPARATOR
Intervention: Control group (PUS procedure without emission)
Number of subjects: 47
Study 27918196 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral riboflavin incorporated into active treatment pills
Number of subjects: 0
Study 27918196 — intervention group
Group type: EXPERIMENTAL
Intervention: Active study ingredients daidzein and genistein
Number of subjects: 0
Study 27918196 — intervention group
Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 0
Study 25548329 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational text message reminders
Number of subjects: 660
Study 25548329 — intervention group
Group type: COMPARATOR
Intervention: Conventional text message reminders
Number of subjects: 660